Filed: 2/13/2023ACC: 0000950123-23-002007
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $296.72M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
16
Positions
$296.72M
Total AUM (reported)
38.91M
Total Shares
Allocation by class
COMMON STOCK$267.78M90.2%
COMMON STOCK CLASS A$28.94M9.8%
Portfolio Concentration
Top 3$228.90M77.1%
4–10$58.16M19.6%
11–25$9.65M3.3%
Top 3 weight
77.1%
Top 10 weight
96.7%
Voting Authority Distribution
Total shares with voting rights: 38.91M
Sole
Full voting authority
38.91M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole16
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings16
Rows:
Imago Biosciences
SOLEShares3.02M
TypeSH
Market value$108.52M
36.57%
Sole
3.02M
Shared
0.00
None
0.00
Replimune Group
SOLEShares3.36M
TypeSH
Market value$91.44M
30.82%
Sole
3.36M
Shared
0.00
None
0.00
Nuvation Bio
SOLEShares15.07M
TypeSH
Market value$28.94M
9.75%
Sole
15.07M
Shared
0.00
None
0.00
Morphic Holding
SOLEShares597.72K
TypeSH
Market value$15.99M
5.39%
Sole
597.72K
Shared
0.00
None
0.00
Alpine Immune Sciences
SOLEShares2.03M
TypeSH
Market value$14.92M
5.03%
Sole
2.03M
Shared
0.00
None
0.00
Cincor
SOLEShares560.99K
TypeSH
Market value$7.85M
2.65%
Sole
560.99K
Shared
0.00
None
0.00
Kronos Bio
SOLEShares3.82M
TypeSH
Market value$6.19M
2.08%
Sole
3.82M
Shared
0.00
None
0.00
Ikena Oncology
SOLEShares2.25M
TypeSH
Market value$5.98M
2.02%
Sole
2.25M
Shared
0.00
None
0.00
Paratek Pharmaceuticals
SOLEShares1.97M
TypeSH
Market value$3.69M
1.24%
Sole
1.97M
Shared
0.00
None
0.00
Theseus Pharmaceuticals
SOLEShares711.48K
TypeSH
Market value$3.54M
1.19%
Sole
711.48K
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$3.33M
1.12%
Sole
843.75K
Shared
0.00
None
0.00
Immunic Inc
SOLEShares1.79M
TypeSH
Market value$2.50M
0.84%
Sole
1.79M
Shared
0.00
None
0.00
Spruce Biosciences
SOLEShares2.16M
TypeSH
Market value$2.33M
0.79%
Sole
2.16M
Shared
0.00
None
0.00
Syros Pharmaceuticals
SOLEShares251.27K
TypeSH
Market value$902.1K
0.30%
Sole
251.27K
Shared
0.00
None
0.00
Jounce Therapeutics
SOLEShares275.51K
TypeSH
Market value$305.8K
0.10%
Sole
275.51K
Shared
0.00
None
0.00
Senti Biosciences, Inc.
SOLEShares195.79K
TypeSH
Market value$276.1K
0.09%
Sole
195.79K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Imago BiosciencesSOLE | Common Stock | 3.02M | SH | $108.52M 36.57% | 3.02M | 0.00 | 0.00 |
Replimune GroupSOLE | Common Stock | 3.36M | SH | $91.44M 30.82% | 3.36M | 0.00 | 0.00 |
Nuvation BioSOLE | Common Stock Class A | 15.07M | SH | $28.94M 9.75% | 15.07M | 0.00 | 0.00 |
Morphic HoldingSOLE | Common Stock | 597.72K | SH | $15.99M 5.39% | 597.72K | 0.00 | 0.00 |
Alpine Immune SciencesSOLE | Common Stock | 2.03M | SH | $14.92M 5.03% | 2.03M | 0.00 | 0.00 |
CincorSOLE | Common Stock | 560.99K | SH | $7.85M 2.65% | 560.99K | 0.00 | 0.00 |
Kronos BioSOLE | Common Stock | 3.82M | SH | $6.19M 2.08% | 3.82M | 0.00 | 0.00 |
Ikena OncologySOLE | Common Stock | 2.25M | SH | $5.98M 2.02% | 2.25M | 0.00 | 0.00 |
Paratek PharmaceuticalsSOLE | Common Stock | 1.97M | SH | $3.69M 1.24% | 1.97M | 0.00 | 0.00 |
Theseus PharmaceuticalsSOLE | Common Stock | 711.48K | SH | $3.54M 1.19% | 711.48K | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $3.33M 1.12% | 843.75K | 0.00 | 0.00 |
Immunic IncSOLE | Common Stock | 1.79M | SH | $2.50M 0.84% | 1.79M | 0.00 | 0.00 |
Spruce BiosciencesSOLE | Common Stock | 2.16M | SH | $2.33M 0.79% | 2.16M | 0.00 | 0.00 |
Syros PharmaceuticalsSOLE | Common Stock | 251.27K | SH | $902.1K 0.30% | 251.27K | 0.00 | 0.00 |
Jounce TherapeuticsSOLE | Common Stock | 275.51K | SH | $305.8K 0.10% | 275.51K | 0.00 | 0.00 |
Senti Biosciences, Inc.SOLE | Common Stock | 195.79K | SH | $276.1K 0.09% | 195.79K | 0.00 | 0.00 |